Pyxis Oncology, Inc. (PYXS) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Pyxis Oncology, Inc. (PYXS) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

PYXS Income Statement

Pyxis Oncology, Inc. (PYXS) annual income statement — 7-year revenue, gross profit & net income history

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Sales/Revenue	0	0	11.04M	0	2.82M	0	0	0	0	16.15M	0	0	0	0	0	0	0	0	0	0
Revenue Growth %	-100%	-	-	-	-	-100%	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Goods Sold	0	459K	-432K	0	0	0	0	0	0	475K	0	0	0	0	0	0	0	0	0	0
COGS % of Revenue	-	-	-3.91%	-	-	-	-	-	-	2.94%	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	-459K	11.47M	0	2.82M	0	0	0	0	15.67M	0	0	0	0	0	0	0	0	0	0
Gross Margin %	-	-	103.91%	-	100%	-	-	-	-	97.06%	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	-100%	-	-	-	-	-100%	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	25.99M	23.9M	29.77M	23.46M	22.57M	22.91M	40.07M	23.75M	20.03M	21.28M	17.77M	25.35M	18.12M	20.95M	37.97M	28.39M	25.73M	31.39M	16.43M	11.62M
OpEx % of Revenue	-	-	269.66%	-	800.35%	-	-	-	-	131.77%	-	-	-	-	-	-	-	-	-	-
Selling, General & Admin	9.93M	4.38M	5.23M	4.97M	5.44M	5.87M	5.08M	6.01M	6.08M	8.25M	6.16M	10.67M	6.73M	9.05M	8.12M	9.36M	8.56M	11.32M	9.2M	3.77M
SG&A % of Revenue	-	-	47.42%	-	192.8%	-	-	-	-	51.08%	-	-	-	-	-	-	-	-	-	-
Research & Development	16.06M	19.59M	21.71M	17.81M	17.13M	17.04M	14.02M	17.74M	13.95M	13.03M	11.61M	14.69M	11.39M	11.9M	29.85M	19.03M	17.17M	20.07M	7.23M	7.85M
R&D % of Revenue	-	-	196.69%	-	607.55%	-	-	-	-	80.69%	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	0	-71K	1000K	684K	0	0	1000K	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating Income	-25.99M	-24.36M	-18.3M	-23.46M	-19.75M	-22.91M	-40.07M	-23.75M	-20.03M	-5.61M	-17.77M	-25.35M	-18.12M	-20.95M	-37.97M	-28.39M	-25.73M	-31.39M	-16.43M	-11.62M
Operating Margin %	-	-	-165.75%	-	-700.35%	-	-	-	-	-34.71%	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	-31.59%	-6.31%	54.34%	1.23%	1.41%	-308.81%	-125.52%	6.31%	-10.55%	73.25%	53.21%	10.7%	29.56%	33.24%	-131.18%	-144.32%	-333.02%	12.15%	-258.72%	-
EBITDA	-25.69M	-23.9M	-15.41M	-22.93M	-19.21M	-22.36M	-39.52M	-23.02M	-19.45M	-4.49M	-17.08M	-24.83M	-17.6M	-20.76M	-37.78M	-28.19M	-25.57M	-31.23M	-16.27M	-11.46M
EBITDA Margin %	-	-	-139.57%	-	-681.38%	-	-	-	-	-27.8%	-	-	-	-	-	-	-	-	-	-
EBITDA Growth %	-33.69%	-6.88%	61.02%	0.42%	1.19%	-398.15%	-131.42%	7.28%	-10.51%	78.38%	54.8%	11.92%	31.17%	33.51%	-132.24%	-145.97%	-346.66%	12.31%	-268.97%	-
D&A (Non-Cash Add-back)	301K	459K	2.89M	535K	535K	552K	550K	731K	585K	1.12M	690K	523K	524K	190K	192K	200K	159K	158K	158K	159K
EBIT	-25.35M	-23.27M	-17M	-22M	-18.07M	-21.16M	-19.11M	-21.2M	-17.3M	-3.26M	-17.77M	-25.35M	-18.12M	-20.95M	-37.97M	-28.39M	-25.73M	-31.39M	-16.43M	-11.62M
Net Interest Income	0	457K	600K	774K	995K	1.24M	1.62M	1.85M	2.02M	1.55M	1.59M	1.71M	1.66M	1.67M	1.87M	719K	164K	9K	7K	6K
Interest Income	0	457K	600K	774K	995K	1.24M	1.62M	1.85M	2.02M	1.55M	1.59M	1.71M	1.66M	1.67M	1.87M	719K	164K	9K	7K	6K
Interest Expense	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Income/Expense	644K	1.09M	1.29M	1.46M	1.68M	1.76M	2.33M	2.55M	2.73M	2.35M	2.17M	2.31M	2.22M	1.71M	1.87M	719K	164K	9K	-403K	-2.55M
Pretax Income	-25.35M	-23.27M	-17M	-22M	-18.07M	-21.16M	-37.73M	-21.2M	-17.3M	-3.26M	-15.6M	-23.05M	-15.9M	-19.24M	-36.1M	-27.67M	-25.56M	-31.38M	-16.83M	-14.18M
Pretax Margin %	-	-	-154.04%	-	-640.82%	-	-	-	-	-20.17%	-	-	-	-	-	-	-	-	-	-
Income Tax	0	0	1.1M	0	283K	0	-2.16M	0	0	0	0	0	0	0	0	0	0	0	0	0
Effective Tax Rate %	0%	0%	-6.49%	0%	-1.57%	0%	5.73%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Net Income	-25.35M	-23.27M	-18.11M	-22M	-18.35M	-21.16M	-35.57M	-21.2M	-17.3M	-3.26M	-15.6M	-23.05M	-15.9M	-19.24M	-36.1M	-27.67M	-25.56M	-31.38M	-16.83M	-14.18M
Net Margin %	-	-	-164.03%	-	-650.85%	-	-	-	-	-20.17%	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	-38.1%	-9.99%	49.1%	-3.77%	-6.09%	-549.82%	-128.06%	8.01%	-8.8%	83.08%	56.8%	16.71%	37.79%	38.68%	-114.52%	-95.23%	-213.8%	14.79%	-267.53%	-
Net Income (Continuing)	-25.35M	-23.27M	-18.11M	-22M	-18.35M	-21.16M	-35.57M	-21.2M	-17.3M	-3.26M	-15.6M	-23.05M	-15.9M	-19.24M	-36.1M	-27.67M	-25.56M	-31.38M	-16.83M	-14.18M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-0.40	-0.37	-0.29	-0.35	-0.30	-0.35	-0.58	-0.35	-0.29	-0.06	-0.35	-0.56	-0.41	-0.50	0.65	-0.83	-0.78	-0.97	-0.53	-0.45
EPS Growth %	-33.33%	-5.71%	50%	0%	-3.45%	-451.18%	-65.71%	37.5%	29.27%	87.3%	-153.85%	32.53%	47.44%	48.45%	222.64%	-84.44%	-200%	41.57%	-152.38%	-
EPS (Basic)	-0.40	-0.37	-0.29	-0.35	-0.30	-0.35	-0.58	-0.35	-0.29	-0.06	-0.35	-0.56	-0.41	-0.50	0.65	-0.83	-0.78	-0.97	-0.53	-0.45
Diluted Shares Outstanding	63.99M	63.47M	62.14M	62.56M	61.92M	61.05M	60.72M	60.72M	60.5M	51.29M	44.75M	41.33M	38.39M	35.35M	34.96M	32.56M	32.45M	32.32M	31.73M	31.73M
Basic Shares Outstanding	63.99M	63.47M	62.14M	62.56M	61.92M	61.05M	60.72M	60.72M	60.5M	51.29M	44.75M	41.33M	38.39M	35.35M	34.96M	32.56M	32.45M	32.32M	31.73M	31.73M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-